Caitlyn T Solem

4PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematological tumoursCross-sectional analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 15, 2022
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma.

Mahmoud Elsawy, Julio C Chavez, Irit Avivi

|Mar 04, 2021
Psychometric Validation of the EQ-5D-3L in Patients with Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium avium Complex (MAC).

Anuj Shah, Xinyi Ng, Ruchit Shah

|Jul 23, 2020
A quality-adjusted survival time without symptoms or toxicities analysis of glasdegib plus low-dose cytarabine versus low-dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapy.

Caitlyn T Solem, Timothy J Bell, Youngmin Kwon

|Feb 06, 2020
Costs and Cost Drivers Associated with Non-Small-Cell Lung Cancer Patients Who Received Two or More Lines of Therapy in Europe.

Katharina Verleger, John R Penrod, Melinda Manley Daumont

Pageof 1

Frequent Collaborators

1 joint publications

Xinyi Ng

1 joint publications

Ruchit Shah

1 joint publications

Kathleen Dorritie

1 joint publications

Samantha Jaglowski